Viewing Study NCT01316757


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-31 @ 4:54 AM
Study NCT ID: NCT01316757
Status: COMPLETED
Last Update Posted: 2018-02-26
First Post: 2011-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module